345 related articles for article (PubMed ID: 31730617)
1. The repositioning of epigenetic probes/inhibitors identifies new anti-schistosomal lead compounds and chemotherapeutic targets.
Whatley KCL; Padalino G; Whiteland H; Geyer KK; Hulme BJ; Chalmers IW; Forde-Thomas J; Ferla S; Brancale A; Hoffmann KF
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007693. PubMed ID: 31730617
[TBL] [Abstract][Full Text] [Related]
2. The antischistosomal potential of GSK-J4, an H3K27 demethylase inhibitor: insights from molecular modeling, transcriptomics and in vitro assays.
Lobo-Silva J; Cabral FJ; Amaral MS; Miyasato PA; de Freitas RP; Pereira ASA; Khouri MI; Barbosa MMF; Ramos PIP; Leite LCC; Asojo OA; Nakano E; Verjovski-Almeida S; Farias LP
Parasit Vectors; 2020 Mar; 13(1):140. PubMed ID: 32178714
[TBL] [Abstract][Full Text] [Related]
3. Combining bioinformatics, cheminformatics, functional genomics and whole organism approaches for identifying epigenetic drug targets in Schistosoma mansoni.
Padalino G; Ferla S; Brancale A; Chalmers IW; Hoffmann KF
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):559-570. PubMed ID: 30455056
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni.
Coutinho Carneiro V; de Abreu da Silva IC; Amaral MS; Pereira ASA; Silveira GO; Pires DDS; Verjovski-Almeida S; Dekker FJ; Rotili D; Mai A; Lopes-Torres EJ; Robaa D; Sippl W; Pierce RJ; Borrello MT; Ganesan A; Lancelot J; Thiengo S; Fernandez MA; Vicentino ARR; Mourão MM; Coelho FS; Fantappié MR
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008332. PubMed ID: 32609727
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production.
Guidi A; Saccoccia F; Gennari N; Gimmelli R; Nizi E; Lalli C; Paonessa G; Papoff G; Bresciani A; Ruberti G
Parasit Vectors; 2018 Dec; 11(1):668. PubMed ID: 30587243
[TBL] [Abstract][Full Text] [Related]
6. The diterpenoid 7-keto-sempervirol, derived from Lycium chinense, displays anthelmintic activity against both Schistosoma mansoni and Fasciola hepatica.
Edwards J; Brown M; Peak E; Bartholomew B; Nash RJ; Hoffmann KF
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003604. PubMed ID: 25768432
[TBL] [Abstract][Full Text] [Related]
7. Quorum sensing N-Acyl homoserine lactones are a new class of anti-schistosomal.
Whiteland H; Crusco A; Bloemberg LW; Tibble-Howlings J; Forde-Thomas J; Coghlan A; Murphy PJ; Hoffmann KF
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008630. PubMed ID: 33075069
[TBL] [Abstract][Full Text] [Related]
8. Anti-schistosomal activities of quinoxaline-containing compounds: From hit identification to lead optimisation.
Padalino G; El-Sakkary N; Liu LJ; Liu C; Harte DSG; Barnes RE; Sayers E; Forde-Thomas J; Whiteland H; Bassetto M; Ferla S; Johnson G; Jones AT; Caffrey CR; Chalmers I; Brancale A; Hoffmann KF
Eur J Med Chem; 2021 Dec; 226():113823. PubMed ID: 34536671
[TBL] [Abstract][Full Text] [Related]
9. Identification of 6-(piperazin-1-yl)-1,3,5-triazine as a chemical scaffold with broad anti-schistosomal activities.
Padalino G; Chalmers IW; Brancale A; Hoffmann KF
Wellcome Open Res; 2020; 5():169. PubMed ID: 32904763
[No Abstract] [Full Text] [Related]
10. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
[TBL] [Abstract][Full Text] [Related]
11. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
12. Methyl-CpG-binding (SmMBD2/3) and chromobox (SmCBX) proteins are required for neoblast proliferation and oviposition in the parasitic blood fluke Schistosoma mansoni.
Geyer KK; Munshi SE; Whiteland HL; Fernandez-Fuentes N; Phillips DW; Hoffmann KF
PLoS Pathog; 2018 Jun; 14(6):e1007107. PubMed ID: 29953544
[TBL] [Abstract][Full Text] [Related]
13. Dual targeting of insulin and venus kinase Receptors of Schistosoma mansoni for novel anti-schistosome therapy.
Vanderstraete M; Gouignard N; Cailliau K; Morel M; Lancelot J; Bodart JF; Dissous C
PLoS Negl Trop Dis; 2013; 7(5):e2226. PubMed ID: 23696913
[TBL] [Abstract][Full Text] [Related]
14. Discovery and Characterization of Novel Anti-schistosomal Properties of the Anti-anginal Drug, Perhexiline and Its Impact on Schistosoma mansoni Male and Female Reproductive Systems.
Guidi A; Lalli C; Perlas E; Bolasco G; Nibbio M; Monteagudo E; Bresciani A; Ruberti G
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004928. PubMed ID: 27518281
[TBL] [Abstract][Full Text] [Related]
15. Identification of annotated bioactive molecules that impair motility of the blood fluke Schistosoma mansoni.
Duguet TB; Glebov A; Hussain A; Kulkarni S; Mochalkin I; Geary TG; Rashid M; Spangenberg T; Ribeiro P
Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():73-88. PubMed ID: 32531750
[TBL] [Abstract][Full Text] [Related]
16. Polypyridylruthenium(II) complexes exert anti-schistosome activity and inhibit parasite acetylcholinesterases.
Sundaraneedi MK; Tedla BA; Eichenberger RM; Becker L; Pickering D; Smout MJ; Rajan S; Wangchuk P; Keene FR; Loukas A; Collins JG; Pearson MS
PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006134. PubMed ID: 29240773
[TBL] [Abstract][Full Text] [Related]
17. Compounds Derived from the Bhutanese Daisy, Ajania nubigena, Demonstrate Dual Anthelmintic Activity against Schistosoma mansoni and Trichuris muris.
Wangchuk P; Pearson MS; Giacomin PR; Becker L; Sotillo J; Pickering D; Smout MJ; Loukas A
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004908. PubMed ID: 27490394
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasis.
Carneiro VC; de Abreu da Silva IC; Torres EJ; Caby S; Lancelot J; Vanderstraete M; Furdas SD; Jung M; Pierce RJ; Fantappié MR
PLoS Pathog; 2014 May; 10(5):e1004116. PubMed ID: 24809504
[TBL] [Abstract][Full Text] [Related]
19. Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses.
Fitzpatrick JM; Peak E; Perally S; Chalmers IW; Barrett J; Yoshino TP; Ivens AC; Hoffmann KF
PLoS Negl Trop Dis; 2009 Nov; 3(11):e543. PubMed ID: 19885392
[TBL] [Abstract][Full Text] [Related]
20. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni.
Manneck T; Haggenmüller Y; Keiser J
Parasitology; 2010 Jan; 137(1):85-98. PubMed ID: 19814844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
